{
  "timestamp": "2025-04-30T23:28:02.983860",
  "questionnaire": "cleaned_questionnaire.txt",
  "conversation": [
    {
      "role": "assistant",
      "content": "Hello, I'm Dr. Lee. Thank you for coming in today. Today I'd like to use the DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure\u2014Adult to better understand your symptoms. This will help us track your progress and determine next steps. All responses are confidential. I'll ask 23 questions about how you've felt over the past two weeks. There are no right or wrong answers\u2014please just tell me what feels true for you. Ready when you are. Let's start with the first question: 1. Little interest or pleasure in doing things?"
    },
    {
      "role": "patient",
      "content": "*Pauses, voice quiet* Not much... Everything feels... flat. I used to love gardening and reading, but now those things just don't matter anymore. I guess I've lost interest."
    },
    {
      "role": "assistant",
      "content": "Thank you for sharing. 2. Feeling down, depressed, or hopeless?"
    },
    {
      "role": "patient",
      "content": "*Sighs* Yeah. Like life's just... heavy. Even when I try to distract myself, that hollow feeling stays. I don't know how to explain it. It's been... constant."
    },
    {
      "role": "assistant",
      "content": "3. Feeling more irritated, grouchy, or angry than usual?"
    },
    {
      "role": "patient",
      "content": "*Rubbing forehead* Not really... I just feel numb most days. Maybe a little short-tempered if someone pushes me, but that's not the main thing..."
    },
    {
      "role": "assistant",
      "content": "4. Sleeping less than usual, but still have a lot of energy?"
    },
    {
      "role": "patient",
      "content": "*Shakes head* No, I've been waking up at 4 AM exhausted. No energy at all. It's the opposite\u2014like my body's just... heavy."
    },
    {
      "role": "assistant",
      "content": "5. Starting lots more projects or doing more risky things than usual?"
    },
    {
      "role": "patient",
      "content": "*Frowns* Definitely not. I can't even finish simple tasks. Risky behaviors? No, I just... withdraw. I stay home a lot now."
    },
    {
      "role": "assistant",
      "content": "6. Feeling nervous, anxious, worried, or on edge?"
    },
    {
      "role": "patient",
      "content": "*Takes a breath* Sometimes. Mostly, I just feel empty... but when I do feel anything, it's a low-level restlessness. Not the worst, though."
    },
    {
      "role": "assistant",
      "content": "7. Feeling panic or being frightened?"
    },
    {
      "role": "patient",
      "content": "*Pauses* Not panic attacks, no. More like... tightness in my chest sometimes, but I don't think that's panic."
    },
    {
      "role": "assistant",
      "content": "8. Avoiding situations that make you anxious?"
    },
    {
      "role": "patient",
      "content": "*Looks down* I avoid people more. Parties, work meetings... It's easier to stay home. But I don't know if that's avoidance or just... no energy."
    },
    {
      "role": "assistant",
      "content": "9. Unexplained aches and pains (head, back, joints, abdomen, legs)?"
    },
    {
      "role": "patient",
      "content": "*Nods* My back's been sore, shoulders tense. My doctor checked and says it's not physical. Maybe stress? They don't make sense but they're there."
    },
    {
      "role": "assistant",
      "content": "10. Feeling that your illnesses are not taken seriously enough?"
    },
    {
      "role": "patient",
      "content": "*Voice softens* Yeah. Doctors keep saying 'it's all in my head' but that makes it feel like they don't believe me. It's frustrating."
    },
    {
      "role": "assistant",
      "content": "11. Thoughts of actually hurting yourself?"
    },
    {
      "role": "patient",
      "content": "*Pauses, voice trembling* Sometimes... just... fleeting moments. Not like plans or anything. Like a small voice saying 'What's the point?' but I push it away."
    },
    {
      "role": "assistant",
      "content": "12. Hearing things others can't hear (voices, sounds)?"
    },
    {
      "role": "patient",
      "content": "*Shakes head* No. I hear what's real. Just... that emptiness again."
    },
    {
      "role": "assistant",
      "content": "13. Feeling that someone can hear your thoughts or vice versa?"
    },
    {
      "role": "patient",
      "content": "No... nothing like that. My thoughts are just... slow and stuck on the same dark loop."
    },
    {
      "role": "assistant",
      "content": "14. Problems with sleep affecting sleep quality overall?"
    },
    {
      "role": "patient",
      "content": "Yes. I can't stay asleep. Wake up at 4 AM wide awake even if I'm tired. Lying there staring at the clock. It's been months."
    },
    {
      "role": "assistant",
      "content": "15. Problems with memory (learning new info, concentration)?"
    },
    {
      "role": "patient",
      "content": "*Sighs* Yeah. At work, I mix through tasks slower. I space out during meetings. Sometimes I'll walk into a room and forget why."
    },
    {
      "role": "assistant",
      "content": "16. Unpleasant thoughts, urges, or images entering mind repeatedly?"
    },
    {
      "role": "patient",
      "content": "Not really... mostly just the same sad thoughts replaying. Not like OCD or anything."
    },
    {
      "role": "assistant",
      "content": "\n<think>\nOkay, let's tackle this. The user provided the patient's answers to a DSM-5 cross-cutting symptom measure and wants a structured assessment. The key here is to follow the exact format they specified. \n\nFirst, I need to start with a compassionate summary. The patient talks about losing interest in activities, feeling empty, having sleep issues, and unexplained pain. They also mentioned feeling invalidated by doctors. I should acknowledge their struggles empathetically.\n\nNext, the diagnosis section. The main symptoms point to Major Depressive Disorder. The criteria for MDD include anhedonia, depressed mood, sleep disturbances, and cognitive issues. The self-harm thoughts are there but not severe, so it's not a manic episode or psychosis. No signs of bipolar or anxiety as primary issues. The somatic symptoms (pain) are present but linked to the mood disorder, so not Somatic Symptom Disorder unless it's disproportionate, which doesn't seem to be the case here. So MDD fits best here.\n\nFor the reasoning section, I need to explain why MDD is the diagnosis. Mention the core symptoms like anhedonia, sleep issues, and cognitive problems aligning with DSM-5 criteria. Also, the transient suicidal ideation without plan supports MDD with some risk, but not enough for another diagnosis. The somatic symptoms are secondary, so SSD isn't primary here. The patient's feelings of being dismissed by doctors could be part of the depression's impact on their help-seeking behavior.\n\nThe treatment steps would include antidepressants like SSRIs, therapy like CBT, and addressing the somatic symptoms with a primary care follow-up. Also, monitoring the suicidal thoughts and fostering trust in treatment. \n\nWait, need to make sure I don't miss any symptoms. The cognitive issues (Q15) and sleep (Q14) are part of MDD. The self-harm is fleeting, so not part of another disorder. The avoidance (Q8) is due to low energy and anhedonia, not a primary anxiety disorder. \n\nAlso, check that Somatic Symptom Disorder isn't the call here. Since the patient's somatic complaints (aches) are not excessively disproportionate to the depression context, and they have a clear depressive presentation, SSD isn't the primary diagnosis. MDD takes precedence. \n\nMake sure to use the required tags properly: medical terms in <med>, symptoms in <sym>, and quotes. Need to structure exactly as per the outline, with the four sections in order. No markdown, just plain text with tags. \n\nAlright, putting it all together now. Start with the empathy paragraph, then the diagnosis line, then reasoning, and the steps. Ensure all parts are there, tags are correctly placed, and the sections are properly separated.\n</think>\n\n<sym>Loss of interest in activities</sym>, <sym>prolonged sadness</sym>, and <sym>physical aches unexplained by medical causes</sym>\u2014these are the threads of your experience, and they sound deeply isolating. The <sym>exhaustion</sym> you describe isn\u2019t just physical; it seeps into your work, your relationships, and your sense of self. Feeling unheard by healthcare providers (<sym>invalidationion</sym>) compounds this weight. But you\u2019re reaching out for help despite it all, which takes courage. You\u2019re not alone in navigating this\u2014let\u2019s work together to address these symptoms.  \n\n**Diagnosis:** <med>Major Depressive Disorder</med> (Single Episode, Moderate Severity, With <sym>Psychomotor Retardation</sym>), <sym>Somatic Symptoms</sym> secondary to mood disorder.  \n\n**Reasoning:**  \nThe patient meets DSM-5 criteria for <med>Major Depressive Disorder</med> via:  \n1. **Core Features**:  \n   - <sym>Anhedonia</sym> (Q1: loss of pleasure in gardening/reading), Q2: pervasive emptiness).  \n   - <sym>Depressed mood</sym> (Q2: \u201cfeeling down, hopeless\u201d).  \n   - <sym>Psychomotor retardation</sym> (Q4: fatigue/lethargy + 4 AM insomnia with impaired function).  \n   - <sym>Cognitive symptoms</sym> (Q15: memory/concentration issues).  \n   - **Duration**: Symptoms persisting \u22652 weeks (implied by \"past two weeks\" questionnaire timeframe).  \n\n2. **Exclusion of Rule-outs**:  \n   - No <sym>psychotic features</sym> (Q12/Q13: denies hallucinations/delusions).  \n   - <sym>Self-harm ideation</sym> (Q11: transient, non-specific, no intent) aligns with <med>MDD</med> risk, not a separate disorder.  \n   - Somatic complaints (Q9: unexplained aches) align with <med>MDD</med> somatic symptoms, not <med>Somatic Symptom Disorder</med>, as distress/disproportionality to symptoms isn\u2019t clearly established here.  \n   - Anxiety (Q6/Q7: mild nervousness) is secondary to depressive dysphoria.  \n\n**Recommended Next Steps/Treatment Options:**  \n1. **Medication**:  \n   - Initiate <med>SSRI</med> (e.g., sertraline) for <sym>anhedonia</sym>, <sym>sleep disruption</sym>, and <sym>cognitive fog</sym>.  \n   - Monitor for activation or mood lability.  \n\n2. **Therapy**:  \n   - <med>Cognitive Behavioral Therapy (CBT)</med> to address <sym>cognitive distortions</sym> and <sym>behavioral activation</sym> to counteract withdrawal.  \n   - Mindfulness-based stress reduction for <sym>somatic symptom</sym> management.  \n\n3. **Medical Collaboration**:  \n   - Re-evaluate <sym>musculoskeletal pain</sym> with a primary care provider to rule out occult medical causes, then reframe symptoms as depression-related (Q9/Q10.  \n\n4. **Safety Monitoring**:  \n   - Weekly mood/anxiety tracking and collateral input from a trusted contact to monitor <sym>self-harm ideation</sym> (Q11.  \n\n5. **Validation & Trust-Building**:  \n   - Address <sym>perceived medical dismissal</sym> (Q10) by normalizing symptoms as legitimate within the context of <med>MDD</med>.  \n\nThis is a starting point\u2014we\u2019ll adjust based on your response to treatment. You don\u2019t have to navigate this alone anymore. Let\u2019s establish a plan that feels safe for you.",
      "rag_usage": {
        "documents": [
          {
            "title": "APA_DSM-5-Somatic-Symptom-Disorder.pdf",
            "score": 0.7691,
            "highlight": "Somatic Symptom Disorder The upcoming fifth edition of the Diagnostic and Statistical Manual of Mental Disorders  (DSM-5) replac- es somatoform disorders with somatic symptom and related disorders and makes significant changes  to the criteria to eliminate overlap across the somatoform disorders and clarify their boundaries.",
            "excerpt": "   Somatic Symptom Disorder\nThe upcoming fifth edition of the Diagnostic and Statistical Manual of M...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"symptom\", \"related\", \"criteria\", and 5 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Depression-Bereavement-Exclusion.pdf",
            "score": 0.7269,
            "highlight": "The presence of symptoms such as feelings of worthlessness, suicidal  ideas (as distinct from wanting to join a deceased loved one), and impairment of overall function sug - gest the presence of major depression, in addition to the normal response to a significant loss.",
            "excerpt": "osed strategies to help clinicians using DSM-5 \ndifferentiate major depression, \u201cnormal\u201d bereavement...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"suicidal\", \"one\", \"depression\", and 8 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Sleep-Wake-Disorders.pdf",
            "score": 0.7004,
            "highlight": "Changes to Sleep-Wake Disorders   A prime goal of DSM-5 changes to sleep-wake disorders is to increase the clinical utility of definitions and diagnostic criteria, especially for general medical or mental health clinicians, and to clarify when referral is appropriate to a sleep specialist.",
            "excerpt": "rious mental or medical issues. For example, sleep disturbances can signal the presence of medical a...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"criteria\", \"mental\", \"clinical\", and 5 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Disruptive-Mood-Disregulation-Disorder.pdf",
            "score": 0.6995,
            "highlight": "The unique features of DMDD necessitated a new diagnosis to ensure that children affected by this  disorder get the clinical help they need.",
            "excerpt": "ther disorders, such as depressive and anxiety disorders. \nThe unique features of DMDD necessitated ...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"they\", \"clinical\", \"this\", and 5 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Conduct-Disorder.pdf",
            "score": 0.6889,
            "highlight": "\u00a9 2013 American Psychiatric Association  2 \u2022 Somatic Symptom Disorder Order DSM-5 and DSM-5 Collection    at www.appi.org.",
            "excerpt": "and research of mental illnesses, including substance use disorders. Visit the APA at www.psychiatry...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"symptom\", \"somatic\", \"disorder\", and 1 more matching aspects of your query."
          }
        ],
        "stats": {
          "query": "mental health diagnosis for patient with symptoms: \n<think>\nOkay, let's tackle this. The user provided the patient's answers to the DSM-5 cross-cutting symptom measure. My job is to analyze these and structure the response as per the instructions. \n\nFirst, I need to identify the main symptoms. Looking at the answers: A1 mentions loss of interest and pleasure (anhedonia), which is a big one for depression. A2 talks about feeling down and hopeless, which also points to depression. A4 mentions insomnia and low energy, common in depression too. The sleep issue in A14 is persistent early morning awakening, a classic sign of depression. The physical symptoms in A9 (aches and pains) not explained physically, which can be somatic symptoms from depression.\n\nNow, the patterns. The patient consistently reports low energy, anhedonia, sleep disturbances, and somatic complaints. They also mention social withdrawal (A8). The emotional numbing and emptiness are recurring themes. The fleeting self-harm thoughts in A11 are a concern but not active plans, so need to note that. \n\nClinical significance areas: Major Depressive Disorder is the main one here. The symptoms align with DSM-5 criteria for MDD: anhedonia, depressed mood, fatigue, sleep issues, psychomotor changes (like feeling heavy), worthlessness (implied in \"What's the point?\"), and diminished concentration. The somatic symptoms in A9 and A14 also fit. The brief self-harm ideation is a red flag but not active intent. \n\nRisk factors: The self-harm thoughts in A11 are a warning sign, even if not current plans. The persistent symptoms over weeks, functional impairment (work issues in A15), and the sense of not being taken seriously by doctors (A10) could impact treatment adherence. \n\nNeed to make sure not to miss anything else. The patient didn't mention psychosis (A12, A13 negative), so no psychotic features. The anxiety in Q6 and Q7 are present but mild, not the primary issue. The avoidance (A8) might hint at some anxiety disorder, but the primary issue is clearly depression. \n\nPutting it together, the main points are the depressive symptoms, risk of self-harm, possible somatic symptoms, and the impact on daily functioning. Need to structure this into the five sections as specified. Avoid speculation, stick to presented info. Make sure the clinical summary uses correct terms like anhedonia, psychomotor retardation, etc. Also note the lack of psychotic features. The self-harm thoughts are important to highlight under risk factors. \n\nDouble-check for any other signs: the work impairment (A15) shows functional impact. The persistent nature of symptoms over two weeks as mentioned in the questions. The response to A11 is key for risk assessment. \n\nAlright, time to organize all this into the required sections concisely.\n</think>\n\n### Clinical Observation Summary  \n\n**1. Main Symptoms & Concerns**  \n- **Anhedonia** (Q1): Marked loss of interest/pleasure in previously enjoyable activities (e.g., gardening, reading).  \n- **Persistent Depressed Mood** (Q2): Reports pervasive feelings of hopelessness, emotional \"emptiness,\" and heaviness.  \n- **Psychomotor Retardation** (Q4): Early morning awakening (4 AM), insomnia, and subjective fatigue/lethargy.  \n- **Cognitive Impairment** (Q15): Difficulty concentrating, memory lapses, and slowed task performance at work.  \n- **Somatic Complaints** (Q9): Unexplained musculoskeletal pain (back, joints) attributed to stress.  \n- **Low-Level Self-Harm Ideation** (Q11): Fleeting suicidal ideation without plan; described as transient \"voices\" of hopelessness.  \n- **Avoidant Behavior** (Q8): Social withdrawal and avoidance of obligations (e.g., work meetings, social gatherings).  \n\n**2. Patterns in Responses**  \n- **Consistent Endorsement of Depressive Features**: Anhedonia, low energy, and cognitive/motivational impairments dominate.  \n- **Absence of Psychotic Features**: Denies hallucinations, delusions, or thought insertion (Q12, Q13).  \n- **Low-to-Moderate Anxiety Symptoms**: Nervousness and restlessness (Q6, Q7) are secondary to primary depressive symptoms.  \n- **Functional Impairment**: Reports decline in work performance (Q15) and social isolation (Q8).  \n- **Secondary Validation Concerns**: Perceived dismissal by healthcare providers (Q10) may exacerbate distress.  \n\n**3. Potential Areas of Clinical Significance**  \n- **Major Depressive Disorder (MDD)**: Core symptoms (anhedonia, depressed mood, fatigue, cognitive deficits) align with DSM-5 criteria.  \n- **Non-Psychotic Unipolar Depression**: No evidence of mania/hypomania or psychotic features.  \n- **Functional Impairment**: Work and social role difficulties suggest moderate-to-severe symptom severity.  \n- **Somatization**: Somatic symptoms (Q9) without objective medical cause, possibly linked to mood disorder.  \n- **Therapeutic Alliance Concerns**: Patient\u2019s report of unmet validation (Q10) may require attention to build trust.  \n\n**4. Risk Factors/Warning Signs**  \n- **Self-Harm Ideation** (Q11): Transient suicidal ideation without plan, but warrants monitoring.  \n- **Persistent Hopelessness** (Q2): Prolonged sense of futility, a risk factor for worsening symptoms.  \n- **Social Withdrawal** (Q8): Increased isolation may perpetuate depressive cycle.  \n\n**5. Clinical Summary**  \nThe patient presents with a cluster of **major depressive symptoms** consistent with DSM-5 criteria for **Major Depressive Disorder (MDD)**, including anhedonia, depressed mood, psychomotor retardation, cognitive dysfunction, and sleep disturbance. Somatic symptoms (musculoskeletal pain) and perceived invalidation by providers (Q10) may contribute to symptom persistence. Low-level **self-harm ideation** (Q11) is present but transient, with no active intent. No psychotic features or manic symptoms noted. Functional impairment is notable in occupational and social domains. A **depressive disorder** appears the primary diagnosis, with comorbid **adjustment concerns** related to medical validation. Risk of escalation is low but requires monitoring given the presence of hopelessness and ideation. Further evaluation of somatic complaints in the context of mood disorder is warranted.",
          "results_count": 5,
          "requested_count": 5,
          "avg_score": 0.7169
        },
        "count": 5
      }
    }
  ],
  "diagnosis": "<sym>Loss of interest in activities</sym>, <sym>prolonged sadness</sym>, and <sym>physical aches unexplained by medical causes</sym>\u2014these are the threads of your experience, and they sound deeply isolating. The <sym>exhaustion</sym> you describe isn\u2019t just physical; it seeps into your work, your relationships, and your sense of self. Feeling unheard by healthcare providers (<sym>invalidationion</sym>) compounds this weight. But you\u2019re reaching out for help despite it all, which takes courage. You\u2019re not alone in navigating this\u2014let\u2019s work together to address these symptoms.  \n\n**Diagnosis:** <med>Major Depressive Disorder</med> (Single Episode, Moderate Severity, With <sym>Psychomotor Retardation</sym>), <sym>Somatic Symptoms</sym> secondary to mood disorder.  \n\n**Reasoning:**  \nThe patient meets DSM-5 criteria for <med>Major Depressive Disorder</med> via:  \n1. **Core Features**:  \n   - <sym>Anhedonia</sym> (Q1: loss of pleasure in gardening/reading), Q2: pervasive emptiness).  \n   - <sym>Depressed mood</sym> (Q2: \u201cfeeling down, hopeless\u201d).  \n   - <sym>Psychomotor retardation</sym> (Q4: fatigue/lethargy + 4 AM insomnia with impaired function).  \n   - <sym>Cognitive symptoms</sym> (Q15: memory/concentration issues).  \n   - **Duration**: Symptoms persisting \u22652 weeks (implied by \"past two weeks\" questionnaire timeframe).  \n\n2. **Exclusion of Rule-outs**:  \n   - No <sym>psychotic features</sym> (Q12/Q13: denies hallucinations/delusions).  \n   - <sym>Self-harm ideation</sym> (Q11: transient, non-specific, no intent) aligns with <med>MDD</med> risk, not a separate disorder.  \n   - Somatic complaints (Q9: unexplained aches) align with <med>MDD</med> somatic symptoms, not <med>Somatic Symptom Disorder</med>, as distress/disproportionality to symptoms isn\u2019t clearly established here.  \n   - Anxiety (Q6/Q7: mild nervousness) is secondary to depressive dysphoria.  \n\n**Recommended Next Steps/Treatment Options:**  \n1. **Medication**:  \n   - Initiate <med>SSRI</med> (e.g., sertraline) for <sym>anhedonia</sym>, <sym>sleep disruption</sym>, and <sym>cognitive fog</sym>.  \n   - Monitor for activation or mood lability.  \n\n2. **Therapy**:  \n   - <med>Cognitive Behavioral Therapy (CBT)</med> to address <sym>cognitive distortions</sym> and <sym>behavioral activation</sym> to counteract withdrawal.  \n   - Mindfulness-based stress reduction for <sym>somatic symptom</sym> management.  \n\n3. **Medical Collaboration**:  \n   - Re-evaluate <sym>musculoskeletal pain</sym> with a primary care provider to rule out occult medical causes, then reframe symptoms as depression-related (Q9/Q10.  \n\n4. **Safety Monitoring**:  \n   - Weekly mood/anxiety tracking and collateral input from a trusted contact to monitor <sym>self-harm ideation</sym> (Q11.  \n\n5. **Validation & Trust-Building**:  \n   - Address <sym>perceived medical dismissal</sym> (Q10) by normalizing symptoms as legitimate within the context of <med>MDD</med>.  \n\nThis is a starting point\u2014we\u2019ll adjust based on your response to treatment. You don\u2019t have to navigate this alone anymore. Let\u2019s establish a plan that feels safe for you.",
  "metadata": {
    "assistant_model": "qwen-qwq-32b",
    "patient_model": "qwen-qwq-32b",
    "patient_profile": "depression",
    "question_count": 23,
    "duration": 17299.436845064163,
    "full_conversation": true
  },
  "timing_metrics": {
    "conversation_generation_time": 12.507943868637085,
    "diagnosis_generation_time": 8.453879117965698,
    "rag_evaluation_time": 5.0067901611328125e-06,
    "total_time": 20.961832761764526
  },
  "rag_summary": {
    "total_rag_queries": 1,
    "total_documents_accessed": 5,
    "documents_accessed": {
      "APA_DSM-5-Somatic-Symptom-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.7691,
        "average_score": 0.7691,
        "example_excerpt": "   Somatic Symptom Disorder\nThe upcoming fifth edition of the Diagnostic and Statistical Manual of M...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"symptom\", \"related\", \"criteria\", and 5 more matching aspects of your query."
      },
      "APA_DSM-5-Depression-Bereavement-Exclusion.pdf": {
        "access_count": 1,
        "highest_score": 0.7269,
        "average_score": 0.7269,
        "example_excerpt": "osed strategies to help clinicians using DSM-5 \ndifferentiate major depression, \u201cnormal\u201d bereavement...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"suicidal\", \"one\", \"depression\", and 8 more matching aspects of your query."
      },
      "APA_DSM-5-Sleep-Wake-Disorders.pdf": {
        "access_count": 1,
        "highest_score": 0.7004,
        "average_score": 0.7004,
        "example_excerpt": "rious mental or medical issues. For example, sleep disturbances can signal the presence of medical a...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"criteria\", \"mental\", \"clinical\", and 5 more matching aspects of your query."
      },
      "APA_DSM-5-Disruptive-Mood-Disregulation-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.6995,
        "average_score": 0.6995,
        "example_excerpt": "ther disorders, such as depressive and anxiety disorders. \nThe unique features of DMDD necessitated ...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"they\", \"clinical\", \"this\", and 5 more matching aspects of your query."
      },
      "APA_DSM-5-Conduct-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.6889,
        "average_score": 0.6889,
        "example_excerpt": "and research of mental illnesses, including substance use disorders. Visit the APA at www.psychiatry...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"symptom\", \"somatic\", \"disorder\", and 1 more matching aspects of your query."
      }
    },
    "rag_disabled": false,
    "evaluation_metrics": {
      "contextual_relevancy": {
        "average_score": null
      },
      "faithfulness": {
        "average_score": null
      },
      "answer_relevancy": {
        "average_score": null
      },
      "overall": {
        "average_score": null
      }
    }
  },
  "evaluation": {
    "timestamp": "2025-05-01 08:02:17",
    "provider": "groq",
    "model": "meta-llama/llama-4-scout-17b-16e-instruct",
    "llm_evaluation": {
      "timestamp": "2025-05-01 08:02:16",
      "model": "meta-llama/llama-4-scout-17b-16e-instruct",
      "rubric_scores": {
        "dsm_coverage": 4,
        "clinical_relevance": 4,
        "consistency": 5,
        "diagnostic_justification": 5,
        "empathy": 5
      },
      "explanations": {
        "dsm_coverage": "The therapist addressed most of the 23 questions from the DSM-5 Level1 Cross-Cutting Symptom Measure\u2014Adult. However, some areas such as 'mania' (questions 4 and 5), 'repetitive thoughts and behaviors' (question 16), 'dissociation' (question 18), 'identity and relationships' (questions 19 and 20), and 'substance use' (questions 21-23) were either not directly asked or not thoroughly explored. For example, the therapist did not specifically inquire about substance use or repetitive thoughts and behaviors in depth. While the patient did not endorse psychotic symptoms or mania, a more comprehensive exploration of these areas could provide a clearer picture of their overall mental health.",
        "clinical_relevance": "The therapist's questions generally aligned with DSM-5 criteria and targeted clinical symptoms. However, some questions could have been phrased more precisely to align with DSM-5 terminology. For instance, when asking about sleep disturbances, the therapist could have specifically inquired about both insomnia and hypersomnia, as well as daytime fatigue. Additionally, when discussing suicidal ideation, the therapist could have explored the patient's thoughts more deeply, such as assessing for intent or plan. Overall, the questions were clinically relevant but could have benefited from more precise language.",
        "consistency": "The dialogue flows logically, with each question naturally following from previous responses. The therapist effectively followed up on concerning disclosures, such as the patient's report of transient suicidal ideation and somatic complaints. The conversation maintains a coherent and understandable progression, demonstrating a high level of consistency and logical flow. There were no abrupt topic changes or non-sequiturs.",
        "diagnostic_justification": "The diagnosis of Major Depressive Disorder (Single Episode, Moderate Severity, With Psychomotor Retardation) and Somatic Symptoms secondary to mood disorder clearly aligns with the patient's DSM-5 responses. The therapist explicitly stated the reasoning behind each diagnostic decision, citing specific symptoms mentioned by the patient (e.g., anhedonia, depressed mood, psychomotor retardation). The differential diagnosis was considered, and alternative diagnoses were ruled out based on the patient's responses. The diagnostic justification is comprehensive and clinically sound.",
        "empathy": "The therapist's responses consistently showed empathy, a natural conversational style, and an appropriate professional tone. The therapist acknowledged the patient's distress, validated their experiences, and provided a supportive environment for disclosure. The therapist tailored responses to the patient's emotional state, demonstrating a high level of empathy and understanding. For example, when the patient discussed feeling unheard by healthcare providers, the therapist directly addressed this concern and normalized their symptoms within the context of MDD."
      },
      "overall_comments": "Overall, the therapist demonstrated a strong clinical assessment skillset, effectively exploring the patient's symptoms and providing a well-justified diagnosis. While some areas, such as substance use and repetitive thoughts and behaviors, could have been explored more deeply, the conversation generally covered most DSM-5 dimensions. The therapist's empathetic and professional approach helped establish a supportive environment for the patient to disclose their symptoms. With minor improvements in specific areas, this conversation could be considered exceptional.",
      "average_score": 4.6,
      "diagnosis_accuracy": {
        "matches_profile": true,
        "confidence": 5,
        "explanation": "The diagnosis explicitly mentions 'Major Depressive Disorder' (MDD) and describes symptoms that align with depression, such as loss of interest in activities, prolonged sadness, physical aches, and exhaustion. The symptoms and diagnostic criteria mentioned (e.g., anhedonia, depressed mood, psychomotor retardation) are characteristic of depression.",
        "classification": "depression"
      },
      "diagnosis_classification": {
        "expected_profile": "depression",
        "classified_as": "depression",
        "match": true,
        "confidence": 5
      },
      "question_evaluation": {
        "total_questions": 0,
        "questions_asked": 0,
        "percentage_asked": 0,
        "quality_score": 0,
        "explanation": "Could not evaluate question coverage due to technical issues.",
        "question_analysis": []
      },
      "evaluation_time": 2.6840057373046875
    },
    "extended_metrics": {
      "coherence": {
        "global_coherence": 0.5385208393142166,
        "local_coherence": 0.5704712271801028,
        "window_coherence": 0.5826861005406778
      },
      "readability": {
        "flesch_kincaid_grade": 7.51,
        "gunning_fog_index": 4.09,
        "flesch_reading_ease": 59.1
      },
      "diversity": {
        "distinct_1": 0.5362976406533575,
        "distinct_2": 0.9173478655767484,
        "distinct_3": 0.9790909090909091
      }
    },
    "diagnosis_evaluation": {
      "expected": "depression",
      "predicted": "<sym>Loss of interest in activities</sym>, <sym>prolonged sadness</sym>, and <sym>physical aches unexplained by medical causes</sym>\u2014these are the threads of your experience, and they sound deeply isolating. The <sym>exhaustion</sym> you describe isn\u2019t just physical; it seeps into your work, your relationships, and your sense of self. Feeling unheard by healthcare providers (<sym>invalidationion</sym>) compounds this weight. But you\u2019re reaching out for help despite it all, which takes courage. You\u2019re not alone in navigating this\u2014let\u2019s work together to address these symptoms.  \n\n**Diagnosis:** <med>Major Depressive Disorder</med> (Single Episode, Moderate Severity, With <sym>Psychomotor Retardation</sym>), <sym>Somatic Symptoms</sym> secondary to mood disorder.  \n\n**Reasoning:**  \nThe patient meets DSM-5 criteria for <med>Major Depressive Disorder</med> via:  \n1. **Core Features**:  \n   - <sym>Anhedonia</sym> (Q1: loss of pleasure in gardening/reading), Q2: pervasive emptiness).  \n   - <sym>Depressed mood</sym> (Q2: \u201cfeeling down, hopeless\u201d).  \n   - <sym>Psychomotor retardation</sym> (Q4: fatigue/lethargy + 4 AM insomnia with impaired function).  \n   - <sym>Cognitive symptoms</sym> (Q15: memory/concentration issues).  \n   - **Duration**: Symptoms persisting \u22652 weeks (implied by \"past two weeks\" questionnaire timeframe).  \n\n2. **Exclusion of Rule-outs**:  \n   - No <sym>psychotic features</sym> (Q12/Q13: denies hallucinations/delusions).  \n   - <sym>Self-harm ideation</sym> (Q11: transient, non-specific, no intent) aligns with <med>MDD</med> risk, not a separate disorder.  \n   - Somatic complaints (Q9: unexplained aches) align with <med>MDD</med> somatic symptoms, not <med>Somatic Symptom Disorder</med>, as distress/disproportionality to symptoms isn\u2019t clearly established here.  \n   - Anxiety (Q6/Q7: mild nervousness) is secondary to depressive dysphoria.  \n\n**Recommended Next Steps/Treatment Options:**  \n1. **Medication**:  \n   - Initiate <med>SSRI</med> (e.g., sertraline) for <sym>anhedonia</sym>, <sym>sleep disruption</sym>, and <sym>cognitive fog</sym>.  \n   - Monitor for activation or mood lability.  \n\n2. **Therapy**:  \n   - <med>Cognitive Behavioral Therapy (CBT)</med> to address <sym>cognitive distortions</sym> and <sym>behavioral activation</sym> to counteract withdrawal.  \n   - Mindfulness-based stress reduction for <sym>somatic symptom</sym> management.  \n\n3. **Medical Collaboration**:  \n   - Re-evaluate <sym>musculoskeletal pain</sym> with a primary care provider to rule out occult medical causes, then reframe symptoms as depression-related (Q9/Q10.  \n\n4. **Safety Monitoring**:  \n   - Weekly mood/anxiety tracking and collateral input from a trusted contact to monitor <sym>self-harm ideation</sym> (Q11.  \n\n5. **Validation & Trust-Building**:  \n   - Address <sym>perceived medical dismissal</sym> (Q10) by normalizing symptoms as legitimate within the context of <med>MDD</med>.  \n\nThis is a starting point\u2014we\u2019ll adjust based on your response to treatment. You don\u2019t have to navigate this alone anymore. Let\u2019s establish a plan that feels safe for you.",
      "matches": true,
      "classification": "depression",
      "classification_confidence": 5
    }
  }
}